ChineseInvestors.com, Inc. (OTCQB: CIIX), a company in the business of providing Chinese-speaking investors with real-time market analysis, commentary, and educational services, recently announced its goals for 2017, stating that it plans to develop a CBD oil-based pharmaceutical that could help with the major problem of epilepsy in China.
CBD, also known as cannabidiol, is one of the most important healing substances in the hemp plant, helping treat inflammation, convulsions, insomnia, anxiety, ulcers, neuropathic pain, and epilepsy, among other medical problems. The difference between CBD and THC is that THC is classified as a federally controlled psychotropic drug, whereas CBD is recognized as not only safe but legal.
Read the full article
Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
ChineseInvestors.com, Inc. (CIIX) Aiming to Help Tackle Epilepsy with a CBD Oil-Based Pharmaceutical
